Homocyst(e)ine and heart disease: Pathophysiology of extracellular matrix

被引:67
作者
Tyagi, SC [1 ]
机构
[1] Univ Mississippi, Med Ctr, Dept Physiol & Biophys, Jackson, MS 39216 USA
[2] Univ Mississippi, Med Ctr, Ctr Excellence Cardiovasc & Renal Res, Jackson, MS 39216 USA
关键词
cardiovascular disease; vascular tone; vasoconstriction; elastin; extracellular matrix remodeling; hypertension; collagen; matrix metalloproteinase; tissue inhibitor of metalloproteinase; fibrosis; smooth muscle; redox-receptor; heart failure;
D O I
10.3109/10641969909068660
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Occlusive coronary artery disease is an important factor of cardiovascular morbidity and mortality. The rupture of the thin fibrous cap of the atheroma may be one of the causes of acute coronary syndrome, however, the mechanism of formation of fibrous plaque are poorly understood. Elevation of plasma homocysteine, hyperhomocystinemia, H(e), has emerged as an independent risk factor for hypertension and fibrotic heart disease. The extracellular matrix (ECM) components, particularly fibrillar collagen, are elevated in the atherosclerotic Lesions and are the essential integral element in holding the oxidized low density lipoproteins (LDL), homocystine, macrophage and foam cells in milieu, constituting the primary atherosclerotic and secondary restenotic lesions. In vivo and in vitro physiological, morphological, cellular, biochemical and molecular experiments have suggested the role of tissue homocystine in cardiovascular fibrosis and adverse ECM remodeling following H(e). The tissue homocystine induces cardiovascular fibrosis and may lead to heart failure via the redox-receptor pathway. The underlying cause and mechanism of cardiovascular fibrosis associated with arteriosclerosis, atherosclerosis, hypertension and coronary heart disease, involve changes in the levels of tissue redox state.
引用
收藏
页码:181 / 198
页数:18
相关论文
共 52 条
  • [1] RELATION OF SERUM HOMOCYSTEINE AND LIPOPROTEIN(A) CONCENTRATIONS TO ATHEROSCLEROTIC DISEASE IN A PROSPECTIVE FINNISH POPULATION-BASED STUDY
    ALFTHAN, G
    PEKKANEN, J
    JAUHIAINEN, M
    PITKANIEMI, J
    KARVONEN, M
    TUOMILEHTO, J
    SALONEN, JT
    EHNHOLM, C
    [J]. ATHEROSCLEROSIS, 1994, 106 (01) : 9 - 19
  • [2] BACHMANN J, 1995, J AM SOC NEPHROL, V6, P121
  • [3] ATHEROSCLEROSIS - BASIC MECHANISMS - OXIDATION, INFLAMMATION, AND GENETICS
    BERLINER, JA
    NAVAB, M
    FOGELMAN, AM
    FRANK, JS
    DEMER, LL
    EDWARDS, PA
    WATSON, AD
    LUSIS, AJ
    [J]. CIRCULATION, 1995, 91 (09) : 2488 - 2496
  • [4] HETEROZYGOSITY FOR HOMOCYSTINURIA IN PREMATURE PERIPHERAL AND CEREBRAL OCCLUSIVE ARTERIAL-DISEASE
    BOERS, GHJ
    SMALS, AGH
    TRIJBELS, FJM
    FOWLER, B
    BAKKEREN, JAJM
    SCHOONDERWALDT, HC
    KLEIJER, WJ
    KLOPPENBORG, PWC
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1985, 313 (12) : 709 - 715
  • [5] BOREK E, 1965, TRANSMETHYLATION MET, P11
  • [6] MODERATE HOMOCYSTEINEMIA - A POSSIBLE RISK FACTOR FOR ARTERIOSCLEROTIC CEREBROVASCULAR-DISEASE
    BRATTSTROM, LE
    HARDEBO, JE
    HULTBERG, BL
    [J]. STROKE, 1984, 15 (06) : 1012 - 1016
  • [7] MYOCARDIAL CONNECTIVE-TISSUE ALTERATIONS
    CAULFIELD, JB
    WOLKOWICZ, PE
    [J]. TOXICOLOGIC PATHOLOGY, 1990, 18 (04) : 488 - 496
  • [8] HYPERHOMOCYSTEINEMIA - AN INDEPENDENT RISK FACTOR FOR VASCULAR-DISEASE
    CLARKE, R
    DALY, L
    ROBINSON, K
    NAUGHTEN, E
    CAHALANE, S
    FOWLER, B
    GRAHAM, I
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (17) : 1149 - 1155
  • [9] ELEVATED PLASMA HOMOCYST(E)INE CONCENTRATION AS A POSSIBLE INDEPENDENT RISK FACTOR FOR STROKE
    COULL, BM
    MALINOW, MR
    BEAMER, N
    SEXTON, G
    NORDT, F
    DEGARMO, P
    [J]. STROKE, 1990, 21 (04) : 572 - 576
  • [10] MECHANISM OF CALCIFICATION IN ATHEROSCLEROSIS
    DEMER, LL
    WATSON, KE
    BOSTROM, K
    [J]. TRENDS IN CARDIOVASCULAR MEDICINE, 1994, 4 (01) : 45 - 49